October 2026

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation ()
News Alert: FDA shares warning about heart valve tech after patient death ()
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval ()
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves ()
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart ()
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks ()
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR ()
TAVR accessories recalled | A new ultrasound strategy | Lab-grown graft delivers | Sutureless heart valves | Coverage concerns ()
News Alert: Siemens Healthineers doubles down on cardiovascular care as it exits general imaging ultrasound business ()
The best hospitals in the world for heart surgery | More momentum for AI-powered CCTA tools | Peripheral IVL vs. atherectomy ()
Top 10 most popular cardiology video interviews this past month ()
The world’s best heart hospitals | Why healthcare costs keep rising | CMS may cover TAVR for AR | New drug now under review ()
The consistent value of intravascular imaging | New LVAD data | The first procedure of its kind | Stroke robot impresses FDA ()
Why healthcare costs keep rising | HeartMate 3 LVAD linked to strokes, other risks | Supplement recalled | On-the-go CCTA scans ()
Previewing TCT 2026 | FDA clears new AI tool | First procedure of its kind performed in US | Intravascular imaging & PCI ()
The world's best heart hospitals | New CVD trends | Real-world thrombectomy data | AHA Scientific Sessions 2026 ()
TAVR Highlights: Medicare covers asymptomatic patients | More policy changes on the way? | AI's impact | The risk of waiting ()
New heart device makes US debut | CT-based extracellular volume assessments | Canon launches TAVR tech | Riverrain & RapidAI ()
Semaglutide & the heart | Pro athlete sues doctors | BP drug recalled | GLP-1 pill makes a difference | A new CVD risk factor ()
CMS may cover TAVR for aortic regurgitation | FDA approves CardioMEMS updates | Lilly's GLP-1 pill | Celebrating outpatient care ()
September's Top Stories: BP drug recalled | Major TAVR changes | AI for heart attack detection | FDA approves small pacemaker ()
Making cardiologists feel safer | New SCAD research | Young children on GLP-1s | Heart attack drug submitted to FDA ()
Cardiology compensation climbs again | FDA OKs first heart valve of its kind | AI improves workflows | Rural practices struggle ()
AI scans routine images to evaluate risk | Looking back at ESC Congress 2026 | New ASNC recommendations | Building a CT program ()
FDA clears heart valve that grows with pediatric patient | Renal denervation assigned CPT I codes | Regenerating heart cells ()
Improving workflows with AI | Expert insights on heart-healthy diets | Startup's big news | Video tech cleared for new surgeries ()